MedTrace Logo

The Characteristics of Regional Bone Quality in the Cervical Vertebrae Considering BMD

NCT02995798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2016-12-16

No results posted yet for this study

Summary

Data of CT images and the femoral neck BMD were obtained from 99 patients who underwent the cervical CT and BMD simultaneously (the gap of both studies was within 6 months) from April 2009 to December 2014. There were 52 females and 47 males. The mean age was 63.7 year (female: 63.4 years, male: 64.1; range 32-86 years). The patient was excluded who had any destructive pathology or severe spondylosis in the cervical pedicle and the cervical lateral mass. Patients were divided into three groups according to femoral neck BMD (Group A, T-score ≥-1; Group B, -2.5\<T-score\<-1.0; Group C, T-score≤-2.5). Group A had normal BMD patients, Group B had lower normal patients including osteopenic patients and Group C presented osteoporotic patients. The mean HU numbers of cortical bone area in the vertebral canal (cHU, the medial wall of the lateral mass), the posterior wall of transverse foramen (fHU), the medial (mHU), lateral wall (lHU) and trabecular area of pedicle (pHU) were measured on the axial CT images in clinical images.

Conditions

  • Cortical Bone Thickness

Interventions

OTHER

Cortical Bone thickness and Hounsfield unit (HU) numbers

Cortical Bone thickness and Hounsfield unit (HU) numbers considering BMD

Sponsors & Collaborators

  • The Catholic University of Korea

    collaborator OTHER

  • Gangneung Asan Hospital

    lead OTHER

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2014-12-31
Completion
2016-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02995798 on ClinicalTrials.gov